U.S. federal trademark · Serial No. 79079465 · Reg. No. 3953541
Scientific, biological, medical and technological research; laboratory services in the field of immunotherapy and identification, characterization and development of antibodies; chemical, biological and biotechnological analyses; discovery and development of medicines; research in the field of identifying, characterizing and developing antibodies
Pharmaceutical and veterinary preparations and substances for immunotherapy, and for the treatment of cancer, Alzheimer´s disease and other conditions which can be treated, relieved or prevented by antibodies that bind to, activate or block, a target antigen
Chemical, biochemical, biological and biotechnological preparations, namely antibodies and antibody fragments for use in developing and producing immunological reagents for industrial and scientific purposes; biological preparations, namely, antibodies and antibody fragments for use in laboratories and clinics for diagnosis and analysis, for scientific and research purposes; carriers and substances for use in producing pharmaceuticals, namely antibodies and antibody fragments, cancer and the testis antigens and antigen fragments, human-derived monoclonal antibodies, NY-ESO-1, CTA-001, B Cell Display Technology-derived substances; chemical, biochemical, biological, and biotechnological products for industrial and scientific use, including use for the development of pharmaceuticals and in biology, namely, antibodies and antibody fragments, human-derived monoclonal antibodies, NY-ESO-1, CTA-001, cancer and the testis antigens and antigen fragments, B Cell Display Technology-derived substances
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.